[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.167.137. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
December 28, 2011

ADHD Medications and Cardiovascular RiskSome Heartening News

Author Affiliations

Author Affiliation: National Human Genome Research Institute, Bethesda, Maryland.

JAMA. 2011;306(24):2723-2724. doi:10.1001/jama.2011.1866

Few medications have received as much public scrutiny as those used for attention-deficit/hyperactivity disorder (ADHD). The most serious concerns have centered on cardiovascular risk. The study by Habel and colleagues1 in this issue of JAMA compared approximately150 000 adults prescribed ADHD medication with approximately 300 000 nonusers and found no evidence of a link between ADHD medications and myocardial infarction, sudden cardiac death, or stroke.

First Page Preview View Large
First page PDF preview
First page PDF preview
×